Related Experiment Video
Updated: Oct 20, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Low lung function, sudden cardiac death and non-fatal coronary events in the general population
Suneela Zaigham1, Karl-Fredrik Eriksson2, Per Wollmer3,4
1Department of Clinical Sciences, Lund University, Malmö, Sweden suneela.zaigham@med.lu.se.
Insights
Reduced lung function, specifically lower forced expiratory volume in 1 second (FEV1), strongly predicts sudden cardiac death (SCD) risk more than non-fatal cardiac events (CE). Spirometry can help assess cardiovascular risk.
Area of Science:
- Cardiology
- Pulmonology
- Epidemiology
Background:
- Sudden cardiac death (SCD) is a leading cause of mortality following acute coronary events (CE).
- Poor lung function is a known predictor of cardiac events, but its differential impact on SCD versus non-fatal CE is unclear.
- This population-based study investigates the relationship between lung function and the risk of future SCD and non-fatal CE.
Purpose of the Study:
- To determine if lung function impairment patterns differ in predicting sudden cardiac death (SCD) compared to non-fatal cardiac events (CE).
- To examine the association between spirometry measures and future SCD and non-fatal CE incidence.
Main Methods:
- Prospective cohort study of 28,584 middle-aged subjects from the Malmö Preventive Project.
- Baseline spirometry (FEV1, FVC, FEV1/FVC) was assessed in individuals with no prior CE history.
- Cox regression models, using a modified Lunn McNeil competing risk method, analyzed the incidence of SCD and non-fatal CE.
Main Results:
- A 1-second reduction in forced expiratory volume (FEV1) showed a stronger association with SCD (HR 1.23) than non-fatal CE (HR 1.08), even after full adjustment (p=0.002).
- Similar associations were observed for forced vital capacity (FVC), but not the FEV1/FVC ratio.
- These findings persisted in lifelong never-smokers, indicating a robust link between lung function and SCD risk.
Conclusions:
- Reduced FEV1 is significantly associated with both SCD and non-fatal CE, but more strongly predicts future SCD.
- Spirometry measurements in earlier life may aid in stratifying individuals at risk for SCD.
- Spirometry is a valuable tool for a comprehensive assessment of overall cardiovascular risk.
Background:
Many of those who suffer from a first acute coronary event (CE) die suddenly during the day of the event, most of them die outside hospital. Poor lung function is a strong predictor of future cardiac events; however, it is unknown whether the pattern of lung function impairment differs for the prediction of sudden cardiac death (SCD) versus non-fatal CEs. We examined measures of lung function in relation to future SCD and non-fatal CE in a population-based study.
Methods:
Baseline spirometry was assessed in 28 584 middle-aged subjects, without previous history of CE, from the Malmö Preventive Project. The cohort was followed prospectively for incidence of SCD (death on the day of a first CE, inside or outside hospital) or non-fatal CE (survived the first day). A modified version of the Lunn McNeil's competing risk method for Cox regression was used to run models for both SCD and non-fatal CE simultaneously.
Results:
A 1-SD reduction in forced expiratory volume in 1 s (FEV1) was more strongly associated with SCD than non-fatal CE even after full adjustment (FEV1: HR for SCD: 1.23 (1.15 to 1.31), HR for non-fatal CE 1.08 (1.04 to 1.13), p value for equal associations=0.002). Similar associations were found for forced vital capacity (FVC) but not FEV1/FVC. The results remained significant even in life-long never smokers (FEV1: HR for SCD: 1.34 (1.15 to 1.55), HR for non-fatal CE: 1.11 (1.02 to 1.21), p value for equal associations=0.038). Similar associations were seen when % predicted values of lung function measures were used.
Conclusions:
Low FEV1 is associated with both SCD and non-fatal CE, but consistently more strongly associated with future SCD. Measurement with spirometry in early life could aid in the risk stratification of future SCD. The results support the use of spirometry for a global assessment of cardiovascular risk.
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

